Newsletter | March 31, 2026

03.31.26 -- UK's Decentralized Manufacturing Could Be A Revolution; Mind The Risk

SPONSOR

This PHC webinar explores how continuous metabolic insight strengthens feeding strategies, improves process understanding, and enables early detection of culture stress to reduce batch risk and improve yield. Learn how next-generation in-line PAT solutions deliver real-time glucose and lactate monitoring using electrochemical sensors. Discover how continuous data supports Quality by Design, reduces variability, and enables more predictive, efficient bioprocess operations. Click here to learn more.

FOCUS ON MANUFACTURING

UK's Decentralized Manufacturing Could Be A Revolution; Mind The Risk

Decentralized manufacture will only improve patient outcomes if the pharmaceutical quality system at the control site is strong enough to carry the weight of the network.

How Beta-Lactams Can Pose A Risk To Your CGTs

Beta-lactam antibiotics pose an invisible contamination risk to CGTs, threatening patient safety and regulatory compliance. Study the critical steps to mitigate this risk in your raw materials.

Anticipating The Next Decade Of Gene Therapy

The next decade will bring improvements in developing alternative approaches to gene delivery, and advances in upstream and downstream processing, analytical methods, and intensified/continuous processing.

Optimize Stem Cell Culture Conditions

Explore how you can revolutionize your stem cell research with a stable, plant-based growth factor that simplifies culture maintenance and boosts cell health.

Introduction To Tangential Flow Filtration

Learn about tangential flow filtration (TFF), typical TFF system configurations, ultrafiltration fundamentals, applications, system selection considerations, and more.

The Rise In Aseptic Manufacturing Solutions With Smaller Footprints

Aseptic drug manufacturing is going small. Uncover how advanced robotic and automated systems with smaller footprints are changing the landscape and boosting accessibility.

Streamline Data For Efficient Therapeutic Manufacturing

An integrated solution for impurity and sterility analysis streamlines data, supports regulatory compliance, and uses built-in algorithms to deliver accurate, actionable results quickly.

Tackle The High Costs Of Developing AAV-Based Therapeutics

Resolve monomers from dimers across AAV serotypes with a breakthrough solution that cuts sample use by up to 90%, accelerates development, and reduces costs—transforming gene therapy workflows.

Simplify Harvest And Media Exchange In Cell Therapy

Scale-up often introduces shear stress and process variability. Low-shear, single-use technology stabilizes media exchange and harvest, ensuring consistent cell quality and predictable performance.

Levers To Optimize The IVT Reaction For Increased mRNA Yield

Mastering IVT yield requires balancing magnesium and nucleotide ratios. Delve into how specific buffers and pyrophosphatase optimize mRNA synthesis for scalable, high-quality therapeutic production.

The Secret To Pure Oligos: Why Anion Exchange Chromatography Rules At Scale

Discover how anion exchange chromatography delivers high loading capacity and clinical-grade purity while addressing common scale-up challenges like aggregation and equipment longevity.

50-Color Spectral Cytometry Panel Links ICANS In Clinical Trials

See how integrated immune profiling reveals biomarkers and mechanistic insights into toxicity and treatment response, driving advances in cell therapy and personalized immunotherapy strategies.

MANUFACTURING SOLUTIONS

CRISPR And LNP Innovation Through Analytics - Cytiva

CRISPR From Research To Therapy - Lonza

Closed Aseptic Multipurpose Isolator - 3P innovation

Cell Culture Vessel - Corning Life Sciences

Connect With Cell & Gene: